Diabetes :: NovoNorm may offer advantages in elderly diabetics
In elderly patients with type 2 or non-insulin dependent diabetes, treatment with the short-acting drug repaglinide (NovoNorm) may be safer than that with the longer-acting drug, glibenclamide (glyburide), Italian researchers report.